摘要:
Phosphonate substituted compounds with HIV protease inhibitory properties having use as therapeutics and for other industrial purposes are disclosed. The compositions inhibit HIV protease activity and/or are useful therapeutically for the treatment of AIDS and other antiviral infections, as well as in assays for the detection of HIV protease.
摘要:
Novel compounds of formula I, with the exception of i) the racemate of (3-amino-2-hydroxypropyl)phosphinic acid; and ii) (2R/S, 3R)-(3-amino-2-hydroxybutyl)phosphinic acid, having affinity to one or more GABAB receptors, their pharmaceutically acceptable salts, solvates and stereoisomers, as well as processes for their preparation, pharmaceutical compositions containing said therapeutically active compounds and the use of said active compounds in therapy.
摘要:
The invention provides compounds of formula I, R1—OP(O)(OH)2 I wherein R1 represents the non-hydroxy portion of a triazole antifungal compound of the type comprising a tertiary hydroxy group; or a pharmaceutically acceptable salt thereof. The compounds of the invention are useful in the treatment of fungal infections, and have good aqueous solubility.
摘要:
Novel compounds of formula I, with the exception of i) the racemate of (3-amino-2-hydroxypropyl)phosphinic acid; and ii) (2R/S,3R)-(3-amino-2-hydroxybutyl)phosphinic acid, having affinity to one or more GABAB receptors, their pharmaceutically acceptable salts, solvates and stereoisomers, as well as processes for their preparation, pharmaceutical compositions containing said therapeutically active compounds and the use of said active compounds in therapy.
摘要:
This invention is directed to process for making a composition having the formula (I): ##STR1## wherein R.sup.3, R.sup.4, and R.sup.5 are independently hydrogen, substituted or unsubstituted hydrocarbyl, or an agronomically acceptable cation. The process comprises contacting a solution with a noble metal catalyst and introducing oxygen into the solution. The solution contains an N-substituted glyphosate having the formula (II): ##STR2## wherein R.sup.1 and R.sup.2 are independently hydrogen, halogen, --PO.sub.3 H.sub.2, --SO.sub.3 H, --NO.sub.2, or substituted or unsubstituted hydrocarbyl other than --CO.sub.2 H. R.sup.3, R.sup.4, and R.sup.5 are as defined for formula (I).This invention also relates to an oxidation catalyst comprising a noble metal having a hydrophobic electroactive molecular species adsorbed thereon.
摘要:
A novel phosphoric acid-amino acid complex salt is provided which manifests insolubility in a neutral or alkaline aqueous solution and solubility in an acidic aqueous solution and has a basic amino acid, an alkaline earth metal, and phosphoric acid as main components thereof. An additive composition containing the complex salt and used in a feed for ruminant mammals excels in protection in the first compartment of the stomach of a ruminant mammal and solubility in the fourth compartment of the stomach. This additive composition improves the nutrition of the feed with respect to such a basic amino acid as lysine, a substance frequently missing in the feed for ruminant mammals.
摘要:
Compounds of the formula ##STR1## where m and n are integers 0 to 10 and m+n equals 0 to 10, (a) X is O or S(b) Z is a covalent bond; a monocyclic or polycyclic carbocycle ring moiety; or a monocyclic or polycyclic heterocyclic ring moiety containing one or more heteroatoms selected from O, S, or N; (c) Q is covalent bond; O; or S; (d) R is COOH, SO.sub.3 H, PO.sub.3 H.sub.2, or P(O)(OH)R.sup.4, wherein R.sup.4 is C.sub.1 -C.sub.8 alkyl; (e) R.sup.1, R.sup.2 and R.sup.5 are as defined in the claims. are useful in the treatment of calcium and phosphate elated disorders, such as arthritis and the like.
摘要:
The present invention relates to compositions comprising pharnaceutically-acceptable carriers and a phosphonocarboxylate, or a pharmaceutically-acceptable salt thereof, having a structure according to formula (I): ##STR1##
摘要:
##STR1## Metal complex of tetra-aza macrocycles of formula (1) wherein Alk 1 , Alk 2 , Alk 3 and Alk 4 , which may be the same or different, is each a C 1-4 alkylene chain optionally substituted by one or more optionally substituted C 1-6 alkyl groups; and R 1 , R 2 , R 3 and R 4 which may be the same or different is each a hydrogen atom or a group AlkR 5 where Alk is an optionally substituted straight or branched C 1-6 alkyl group and R 5 is a hydrogen atom or a --CO 2 H,--CONR 6 R 7 [where R 6 and R 7 , which may be the same or different, is each a hydrogen atom or a C 1-6 alkyl group] or --P(X 1 )(X 2 R 8 )R 9 group where X 1 and X 2 , which may be the same or different is each an oxygen or sulphur atom, R 8 is a hydrogen atom or an alkyl group and R 9 is an aliphatic, aromatic or heteroaromatic group, with the proviso that at least two of R 1 , R 2 , R 3 and R 4 is a group -AlkP(X 1 )(X 2 R 8 )R 9 or one or R 1 , R 2 , R 3 and R 4 is a group -AlkP(X 1 )(X 2 R 8 )R 9 and at least one of the remaining groups R 1 , R 2 , R 3 and R 4 is a group -AlkCO 2 H or -AlkCONR 6 R 7 , or a salt thereof, for use as contrast agents in nuclear magnetic resonance imaging are described.
摘要:
Novel catalytic derivatives of titanium or zirconium complexes containing one and only one cyclic delocalized, anionic, .PI.-bonded group wherein the metal is in the +2 formal oxidation state and having a bridged ligand structure and an activating cocatalyst are useful as catalysts for polymerizing olefins, diolefins and/or acetylenically unsaturated monomers.